KDR 0.00% $1.90 kidman resources limited

To Settle or Not to Settle?, page-29

  1. 916 Posts.
    lightbulb Created with Sketch. 8
    I think once this issue becomes the "critical path" for KDR getting spodumene concentrate or DSO to market, then the chances of KDR dropping its rights to recourse reduces dramatically. The direct cost and economic lost for KDR then becomes very real and presentable to the court. Which is why I think it's equally in MZN interest not to delay a settlement if it finds itself in position to walk away.

    As Sun Tzu once said "Build your opponent a golden bridge to retreat across."
 
watchlist Created with Sketch. Add KDR (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.